Carregant...
PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer
The expression of PD-L1 could be a novel biomarker which predicts that patients are more likely to respond to immunotherapy. Our study investigated the relationship among clinicopathological characteristics, prognosis, PD-L1 expression levels, and FOXP3(+) Treg infiltration. In addition, the relatio...
Guardat en:
| Publicat a: | Dis Markers |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7532998/ https://ncbi.nlm.nih.gov/pubmed/33062072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8843146 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|